Explorer
Debate: Experts share key points after vaccine approval
Drug Controller General of India (DCGI) V.G. Somani on Sunday approved Serum Institute of India's 'Covishield' vaccine and Bharat Biotech's 'Covaxin' for emergency use.
Pune-based Serum Institute of India has partnered with Oxford-AstraZeneca for conducting clinical trials and manufacturing 'Covishield', while Bharat Biotech has collaborated with the Indian Council of Medical Research (ICMR) for 'Covaxin'.
Serum and Bharat Biotech Pfizer had applied for the accelerated approval on December 6 and 7, respectively.
Pune-based Serum Institute of India has partnered with Oxford-AstraZeneca for conducting clinical trials and manufacturing 'Covishield', while Bharat Biotech has collaborated with the Indian Council of Medical Research (ICMR) for 'Covaxin'.
Serum and Bharat Biotech Pfizer had applied for the accelerated approval on December 6 and 7, respectively.
India
BREAKING: BJP Set to Release West Bengal Manifesto on March 28, Amit Shah to Unveil
BREAKING: PM Modi to Address Parliament at 2 PM on Middle East Crisis, Energy & National Security
BREAKING: Delhi Power Prices May Rise From April 2026, Residents Face Higher Electricity Bills
MARKET MELTDOWN: Sensex crashes 1,500 points as Middle East war triggers investor panic
India Alert: PM Modi Chairs CCS Meeting Amid Middle East War Concerns
View More
Top Headlines
World
Iran Speaker Denies US Talks After Israeli Media Names Him Trump’s ‘Top Contact’
World
Colombian Military Plane With 110 Soldiers Crashes During Takeoff Near Peru Border
News
Petrol & Diesel Prices To Increase In Himachal Pradesh, Sukhu Govt Passes Bill
News
Air India Boeing 787 From Bengaluru To London Diverted To Jeddah After Technical Snag
Trending News
Dr Kunwar Pushpendra Pratap Singh
Opinion
